ABCB1
ABCB1 (ATP binding cassette subfamily B member 1, also known as P-gp, MDR1, CD243 and GP170) is a membrane-associated ATP-dependent efflux pump. It moves phospholipids and a broad range of xenobiotic compounds across membranes and is a central mediator of multidrug resistance. Browse Assay Genie's current range of ABCB1 research reagents below, or read on for the biology behind the target.
ABCB1 is an energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells. It acts on xenobiotic compounds with broad substrate specificity and often mediates the development of resistance to anticancer drugs. It also translocates phospholipids: it catalyses the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane, mainly phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins. It may contribute to hepatobiliary and renal excretion of etiocholanolone-3-glucuronate, but appears to have very low activity toward testosterone, androsterone and dihydrotestosterone glucuronates.
The ABCB1 protein belongs to the ABC transporter superfamily and the ABCB family, in the multidrug resistance exporter subfamily (TC 3.A.1.201). ABC proteins transport various molecules across extra- and intra-cellular membranes, and the genes are divided into seven subfamilies: ABC1, MDR/TAP, MRP, ALD, OABP, GCN20 and White. ABCB1 sits in the MDR/TAP subfamily, whose members are involved in multidrug resistance. UniProt places the protein in the cell membrane, including the apical cell membrane, and in the cytoplasm. It also functions as a transporter in the blood-brain barrier. The mouse ortholog is Abcb1b and the rat ortholog is Abcb1.
The ABCB1 gene has been described under several names, including P-gp, MDR1, CD243, GP170, ABC20, p-170, PGY1 and CLCS, and an earlier name was colchicin sensitivity. HGNC lists it among CD molecules, ATP binding cassette subfamily B and ATPase phospholipid transporting genes. Mutations in the gene are associated with colchicine resistance and inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters result in multiple transcript variants.
ABCB1 is an ATP-dependent efflux pump that lowers drug accumulation in resistant cells, making it a key subject in studies of resistance.
The transporter often mediates resistance to anticancer drugs, so it is studied in relation to chemotherapy response.
ABCB1 functions as a transporter in the blood-brain barrier, which makes it relevant to how compounds are handled at this interface.
ABCB1 flops phosphatidylcholine, phosphatidylethanolamine, glucosylceramides and sphingomyelins across the apical membrane, supporting work on phospholipid translocation.
ABCB1 is an ATP-dependent efflux pump that exports xenobiotic compounds and so decreases drug accumulation in multidrug-resistant cells. It also flops phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane and acts as a transporter in the blood-brain barrier.
Yes. P-gp (P-glycoprotein) and MDR1 are aliases of ABCB1. Other names include CD243, GP170, ABC20, p-170, PGY1 and CLCS. HGNC's previous names include colchicin sensitivity and ATP-binding cassette, sub-family B (MDR/TAP), member 1. Multiple transcript variants arise from alternative splicing and alternative promoters.
The mouse ortholog is Abcb1b and the rat ortholog is Abcb1. In humans, mutations in the gene are associated with colchicine resistance and inflammatory bowel disease 13. Check the datasheet of any product for its validated reactivity.
Other ABCB subfamily transporters related to ABCB1 and its role in multidrug resistance.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P08183; product specifications from Assay Genie datasheets.